Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine
Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.
Summary
This an open-label phase Ⅳ clinical trial of live attenuated varicella vaccine manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd.The purpose of this study is to evaluate the immunity persistence of live attenuated varicella vaccine at 6 and 10 years after booster dose.
Official title: An Open-label Clinical Trial to Evaluate the Immunity Persistence of Live Attenuated Varicella Vaccine At 6 and 10 Years After Booster Dose Immunization with Live Attenuated Varicella Vaccine
Key Details
Gender
All
Age Range
8 Years - 16 Years
Study Type
INTERVENTIONAL
Enrollment
414
Start Date
2024-09-16
Completion Date
2031-12
Last Updated
2025-01-27
Healthy Volunteers
Yes
Conditions
Interventions
Live Attenuated Varicella Vaccine
lyophilized powder, subcutaneous injection
Locations (1)
Henan Provincial Center for Disease Control and Prevention
Zhengzhou, Henan, China